Sherbrooke Park Advisers’s Pfizer PFE Stock Holding History

Sherbrooke Park Advisers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-25,737	Closed	-$656K	–	453
2025 Q3	$656K	Buy	+25,737	New	+$635K	0.3%	97
2025 Q2	–	Sell	-15,501	Closed	-$393K	–	715
2025 Q1	$393K	Sell	15,501 -34,591	-69%	-$905K	0.18%	204
2024 Q4	$1.33M	Buy	+50,092	New	+$1.36M	0.42%	19
2024 Q3	–	Sell	-26,269	Closed	-$735K	–	1171
2024 Q2	$735K	Buy	+26,269	New	+$723K	0.13%	258
2023 Q4	–	Sell	-15,935	Closed	-$529K	–	627
2023 Q3	$529K	Sell	15,935 -65	-0.4%	-$2.3K	0.17%	229
2023 Q2	$587K	Sell	16,000 -5,700	-26%	-$222K	0.31%	134
2023 Q1	$885K	Buy	+21,700	New	+$937K	1.34%	7

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sherbrooke Park Advisers's PFE Position: Q4 2025 in Review

Sherbrooke Park Advisers sold out of Pfizer (PFE) in Q4 2025, closing a stake of 25,737 shares — an estimated $656K sold.

Sherbrooke Park Advisers first reported a position in PFE in Q1 2023 and held it in 7 quarters. The position peaked at $1.33M in Q4 2024. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

Sherbrooke Park Advisers reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
Sherbrooke Park Advisers sold 25,737 Pfizer shares in Q4 2025, an estimated $656K.
Sherbrooke Park Advisers first reported a position in Pfizer in Q1 2023 and held it in 7 quarters.
Sherbrooke Park Advisers's Pfizer position peaked at $1.33M in Q4 2024.
2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.